Kabra Drugs Ltd.
| BSE: 524322 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE323K01017 |
| BSE 16:01 | 08 Aug | 4.15 |
0.18 (4.53%) |
OPEN
3.97 |
HIGH
4.16 |
LOW
3.97 |
| NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
| OPEN | 3.97 |
| PREVIOUS CLOSE | 3.97 |
| VOLUME | 4124 |
| 52-Week high | 5.98 |
| 52-Week low | 2.95 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kabra Drugs Ltd. (KABRADRUGS) - Announcements
-
Kabra Drugs Ltd Board Meeting Intimation for Notice Of Board Meeting To Be Held On Saturday August 13Th 2022
06/08/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Announcement under Regulation 30 (LODR)-Change in Directorate
25/07/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Statement Of Investor Complaints For The Quarter Ended June 2022
15/07/2022 | bse
-
Kabra Drugs Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15/07/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Appointment of Company Secretary and Compliance Officer
14/07/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
14/07/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 14 July 2022
14/07/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Intimation for Intimation Of Proposed Board Meeting Of The Board Of Directors
07/07/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Closure of Trading Window
30/06/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Announcement under Regulation 30 (LODR)-Change in Directorate
14/06/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Outcome for Outcome Of Board Meeting Held Thursday 9Th June 2022
09/06/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Intimation for Intimation Of Proposed Board Meeting Of The Board Of Directors
02/06/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Subject: Compliance Certificate Pursuant To Regulation 40(9) And 40(10) Of SEBI (Listing Obligations
02/06/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Submission Of Half Yearly Disclosure On Related Party Transactions.
30/05/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
30/05/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Outcome for Outcome Of The Board Meeting
30/05/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Audited Financial Results For The 4Th Quarter And Financial Year Ended 31St March 2022
30/05/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Intimation for Notice Of Board Meeting To Be Held On Monday May 30Th 2022
23/05/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Appointment of Company Secretary and Compliance Officer
06/05/2022 | bse |
Downlaod PDF -
Kabra Drugs Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 6 May 2022
06/05/2022 | bse |
Downlaod PDF
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
